Skip to main content
VulnerabilityPublished

CVE-2026-95662: Repasat application · Cross-site Scripting

Affects Repasat applicationSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 4.8 Medium : upgrade to Abril patch "20260402" when convenient.

Data as of 15 Nov 2026, 20:25 UTC

CVSS 4.0 base score
4.8Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 14% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in Abril patch "20260402"
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 15 Nov 2026.

What to do

Upgrade Repasat application to Abril patch "20260402".

Affected software

ProductAffectedFixed in
RepasatRepasat applicationAffected
  • =0
Fixed in
  • Abril patch "20260402"

AI-suggested

If you cannot patch yet, users should exercise caution with untrusted input and consider implementing input validation or output encoding as a temporary mitigation.

Description

Cross-Site Scripting vulnerability in the Repasat application. Successful exploitation of this vulnerability could allow an attacker to trick a user into executing arbitrary code in the victim’s browser. The “nomCompetidor” parameter is affected – endpoint “/es/competitors/store”.

References

Community reviews

Loading reviews…